DrugPatentWatch Database Preview
Profile for Canada Patent: 2522579
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Canada Patent: 2522579
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 22, 2024 | Galderma Labs Lp | SOOLANTRA | ivermectin |
Start Trial | Apr 22, 2024 | Galderma Labs Lp | SOOLANTRA | ivermectin |
Start Trial | Apr 22, 2024 | Galderma Labs Lp | SOOLANTRA | ivermectin |
Start Trial | Apr 22, 2024 | Galderma Labs Lp | SOOLANTRA | ivermectin |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |